JP2020529994A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529994A5 JP2020529994A5 JP2020505363A JP2020505363A JP2020529994A5 JP 2020529994 A5 JP2020529994 A5 JP 2020529994A5 JP 2020505363 A JP2020505363 A JP 2020505363A JP 2020505363 A JP2020505363 A JP 2020505363A JP 2020529994 A5 JP2020529994 A5 JP 2020529994A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- compound according
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762538879P | 2017-07-31 | 2017-07-31 | |
| US62/538,879 | 2017-07-31 | ||
| US201862637960P | 2018-03-02 | 2018-03-02 | |
| US62/637,960 | 2018-03-02 | ||
| PCT/US2018/044389 WO2019027905A1 (en) | 2017-07-31 | 2018-07-30 | ORGANOPHOSPHATE DERIVATIVES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529994A JP2020529994A (ja) | 2020-10-15 |
| JP2020529994A5 true JP2020529994A5 (OSRAM) | 2021-09-09 |
Family
ID=65234161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505363A Pending JP2020529994A (ja) | 2017-07-31 | 2018-07-30 | 有機リン酸誘導体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11306111B2 (OSRAM) |
| EP (1) | EP3661513A4 (OSRAM) |
| JP (1) | JP2020529994A (OSRAM) |
| CN (1) | CN111491634A (OSRAM) |
| AU (1) | AU2018312224A1 (OSRAM) |
| CA (1) | CA3071612A1 (OSRAM) |
| WO (1) | WO2019027905A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3661513A4 (en) | 2017-07-31 | 2021-07-14 | January Therapeutics, Inc. | ORGANOPHOSPHATE DERIVATIVES |
| EP3752511A4 (en) | 2018-01-10 | 2021-12-29 | Nucorion Pharmaceuticals, Inc. | Phosphor(n)amidatacetal and phosph(on)atalcetal compounds |
| US11427550B2 (en) | 2018-01-19 | 2022-08-30 | Nucorion Pharmaceuticals, Inc. | 5-fluorouracil compounds |
| CN112218533A (zh) * | 2018-03-02 | 2021-01-12 | 詹纽瑞治疗公司 | 纳米颗粒组合物 |
| WO2020041050A1 (en) * | 2018-08-20 | 2020-02-27 | Cure Biopharma Inc. | Gemcitabine prodrugs |
| WO2020219464A1 (en) * | 2019-04-22 | 2020-10-29 | Ligand Pharmaceuticals, Inc. | Cyclic phosphate compounds |
| GR1009958B (el) * | 2019-04-24 | 2021-03-18 | ΕΝΟΡΑΣΙΣ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΚΑΙ ΙΑΤΡΙΚΩΝ ΥΛΙΚΩΝ ΚΑΙ ΜΗΧΑΝΗΜΑΤΩΝ με δ.τ. "ΕΝΟΡΑΣΙΣ Α.Ε." | Παραγωγα γεμσιταβινης και μεθοδοι δημιουργιας παραγωγων γεμσιταβινης |
| MX2022000573A (es) | 2019-07-17 | 2022-02-10 | Nucorion Pharmaceuticals Inc | Compuestos ciclicos de desoxirribonucleotido. |
| US11708637B2 (en) | 2019-08-13 | 2023-07-25 | The Regents Of The University Of California | Methods of supporting a graphene sheet disposed on a frame support |
| EP4013159B1 (en) * | 2019-09-10 | 2025-07-30 | Sony Group Corporation | Wireless communication device and method |
| KR20230004716A (ko) | 2020-04-21 | 2023-01-06 | 리간드 파마슈티칼스 인코포레이티드 | 뉴클레오티드 프로드러그 화합물 |
| CN116323630A (zh) | 2020-08-24 | 2023-06-23 | 吉利德科学公司 | 磷脂化合物及其用途 |
| TWI811812B (zh) | 2020-10-16 | 2023-08-11 | 美商基利科學股份有限公司 | 磷脂化合物及其用途 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2874016B1 (fr) | 2004-06-30 | 2006-11-24 | Centre Nat Rech Scient Cnrse | Nanoparticules de derives de la gemcitabine |
| CA2618713A1 (en) | 2005-08-12 | 2007-02-22 | Merck & Co., Inc. | Novel 2'-c-methyl and 4'-c-methyl nucleoside derivatives |
| WO2009126401A1 (en) | 2008-04-10 | 2009-10-15 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| CN101732258B (zh) | 2008-11-19 | 2013-12-25 | 复旦大学附属华山医院 | 一种用于肿瘤化疗的纳米微球制剂及其制备方法 |
| GB201016855D0 (en) * | 2010-10-06 | 2010-11-17 | Nucana Biomed Ltd | Chemical compounds |
| SG10201804552WA (en) | 2011-01-24 | 2018-07-30 | Anterios Inc | Nanoparticle compositions, formulations thereof, and uses therefor |
| US20130131008A1 (en) | 2011-10-25 | 2013-05-23 | Board Of Regents, The University Of Texas System | Lipophilic monophosphorylated derivatives and nanoparticles |
| SMT201800662T1 (it) | 2011-12-22 | 2019-01-11 | Alios Biopharma Inc | Nucleotidi, nucleosidi sostituiti e loro analoghi |
| CN103239733A (zh) | 2012-02-09 | 2013-08-14 | 复旦大学附属肿瘤医院 | 一种整合素靶向型载药白蛋白纳米粒制剂及其制备方法 |
| AR092959A1 (es) | 2012-10-17 | 2015-05-06 | Merck Sharp & Dohme | Derivados de nucleosidos 2-metil sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales |
| US20140199404A1 (en) | 2013-01-11 | 2014-07-17 | Abraxis Bioscience, Llc | Method for treating cancer based on level of a nucleoside transporter |
| EP4378461A3 (en) | 2013-03-05 | 2024-09-11 | The Regents of University of California | Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents |
| US8889701B1 (en) * | 2013-10-11 | 2014-11-18 | Alla Chem, Llc | Substituted (S)-(2R,3R,5R)-3-hydroxy-(5-pyrimidin-1-yl)tetrahydrofuran-2-ylmethyl aryl phosphoramidate |
| SG10201804835VA (en) * | 2013-10-11 | 2018-07-30 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| KR20150047336A (ko) | 2013-10-24 | 2015-05-04 | 삼성전자주식회사 | 나노입자, 이를 제조하는 방법, 및 이의 용도 |
| JP6581100B2 (ja) * | 2014-02-06 | 2019-09-25 | リボサイエンス・エルエルシー | インフルエンザｒｎａ複製の阻害剤としての４’−ジフルオロメチル置換ヌクレオシド誘導体 |
| CN106459130A (zh) * | 2014-03-03 | 2017-02-22 | 纽科利制药公司 | 吉西他滨类似物 |
| CN106573011A (zh) | 2014-06-24 | 2017-04-19 | 艾丽奥斯生物制药有限公司 | 取代的核苷、核苷酸和其类似物 |
| TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| WO2016188943A1 (en) * | 2015-05-27 | 2016-12-01 | Idenix Pharmaceuticals Llc | Nucleotides for the treatment of cancer |
| CN104961786B (zh) | 2015-06-05 | 2018-09-25 | 苏州大学 | 基于吉西他滨结构的前体药物及其应用 |
| AU2017206077B2 (en) | 2016-01-08 | 2021-11-18 | The Regents Of The University Of California | Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery |
| EP3661513A4 (en) | 2017-07-31 | 2021-07-14 | January Therapeutics, Inc. | ORGANOPHOSPHATE DERIVATIVES |
| CN112218533A (zh) | 2018-03-02 | 2021-01-12 | 詹纽瑞治疗公司 | 纳米颗粒组合物 |
| US20210007999A1 (en) | 2018-03-02 | 2021-01-14 | January Therapeutics, Inc. | Nanoparticle compositions |
| WO2020041050A1 (en) | 2018-08-20 | 2020-02-27 | Cure Biopharma Inc. | Gemcitabine prodrugs |
| US20210323992A1 (en) | 2018-08-20 | 2021-10-21 | Cure Biopharma Inc. | Gemcitabine prodrugs |
| WO2020223530A1 (en) | 2019-04-30 | 2020-11-05 | Cure Biopharma Inc. | Gemcitabine prodrugs |
| US11708637B2 (en) | 2019-08-13 | 2023-07-25 | The Regents Of The University Of California | Methods of supporting a graphene sheet disposed on a frame support |
-
2018
- 2018-07-30 EP EP18840263.0A patent/EP3661513A4/en not_active Withdrawn
- 2018-07-30 AU AU2018312224A patent/AU2018312224A1/en not_active Abandoned
- 2018-07-30 WO PCT/US2018/044389 patent/WO2019027905A1/en not_active Ceased
- 2018-07-30 JP JP2020505363A patent/JP2020529994A/ja active Pending
- 2018-07-30 US US16/635,469 patent/US11306111B2/en active Active
- 2018-07-30 CA CA3071612A patent/CA3071612A1/en active Pending
- 2018-07-30 CN CN201880063984.4A patent/CN111491634A/zh active Pending